PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure

NCT03161158 NA TERMINATED Results posted

This study evaluates whether tailored, peripheral ultrafiltration complementary to low-dose diuretics is associated with a reduction in cardiovascular mortality in 90 days after randomization and heart failure events in 90 days after discharge than usual care including stepped intravenous diuretics in acutely decompensated chronic heart failure with fluid overload (not fully responsive to diuretic therapy).

Details

Lead sponsor	Fresenius Medical Care Deutschland GmbH
Phase	NA
Status	TERMINATED
Enrolment	62
Start date	Fri Nov 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Aug 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Heart Failure
• Acute Heart Failure

Interventions

• CHIARA-System
• Usual care IV diuretics

Countries

Sweden, Germany